BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39897)

  • 1. Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1979 Aug; 25(2):764-7. PubMed ID: 39897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and crystallization of fimbrial hemagglutinin from Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1979 Jul; 25(1):460-2. PubMed ID: 39033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of an immunoblotting method for identifying the individual proteins in the antigenic complexes of Bordetella pertussis].
    Semina IE; Iankina ZK
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):78-81. PubMed ID: 2568040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.
    Ashworth LA; Irons LI; Dowsett AB
    Infect Immun; 1982 Sep; 37(3):1278-81. PubMed ID: 6127315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on a method for the assay of antibody to Bordetella pertussis fimbrial hemagglutinin after inoculation with pertussis HA vaccine (author's transl)].
    Murase Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):511-23. PubMed ID: 6120200
    [No Abstract]   [Full Text] [Related]  

  • 6. [The phenotypic properties of freshly isolated strains of Bordetella].
    Lapaeva IA; Milanko AIa; Mebel' SM; Siniashina LN; Ferkel' GIa; Khramova NN; Tepliakova AI; Lomonosova GG; Volgina TI; Shumakov IuL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Mar; (3):13-6. PubMed ID: 1678567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR
    Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant of Bordetella pertussis which lacks ability to produce filamentous hemagglutinin.
    Watanabe M; Nakase Y
    Infect Immun; 1982 Mar; 35(3):1018-23. PubMed ID: 6279510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae.
    Cowell JL; Zhang JM; Urisu A; Suzuki A; Steven AC; Liu T; Liu TY; Manclark CR
    Infect Immun; 1987 Apr; 55(4):916-22. PubMed ID: 2881893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphology of cells and hemagglutinogens of Bordetella species: resolution of substructural units in fimbriae of Bordetella pertussis.
    Blom J; Hansen GA; Poulsen FM
    Infect Immun; 1983 Oct; 42(1):308-17. PubMed ID: 6137457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen.
    Granström M; Granström G; Lindfors A; Askelöf P
    J Infect Dis; 1982 Dec; 146(6):741-5. PubMed ID: 6128367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cultivation of Bordetella pertussis under different conditions and a study of the cultures obtained].
    Nikolaeva VB; Roshchupkina MN; Gruber IM; Sviridov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):13-4. PubMed ID: 7661907
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG; Ashworth LA; Miller E; Lambert HP
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against intranasal infection of mice with Bordetella pertussis.
    Robinson A; Ashworth LA; Baskerville A; Irons LI
    Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heptakis (2,6-0-dimethyl)beta-cyclodextrin on cell growth and the production of pertussis toxin and filamentous hemagglutinin in Bordetella pertussis.
    Suzuki Y; Imaizumi A; Ginnaga A; Sato H; Sato Y
    Dev Biol Stand; 1985; 61():89-92. PubMed ID: 2872134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.
    Scheller EV; Cotter PA
    Pathog Dis; 2015 Nov; 73(8):ftv079. PubMed ID: 26416077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasticity of fimbrial genotype and serotype within populations of Bordetella pertussis: analysis by paired flow cytometry and genome sequencing.
    Vaughan TE; Pratt CB; Sealey K; Preston A; Fry NK; Gorringe AR
    Microbiology (Reading); 2014 Sep; 160(Pt 9):2030-2044. PubMed ID: 25028460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene expression signals.
    Walker MJ; Guzmán CA; Rohde M; Timmis KN
    Infect Immun; 1991 May; 59(5):1739-46. PubMed ID: 1708358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.